Based on these results, the frequencies of high (*, CD5 − vs. CD5+, p < 0.01) and low positivity (**, CD5- vs. CD5+, p < 0.01) were significantly different between CD5-negative and CD5-positive DLBCL (Fig. 5f). Here, CD5 is linked to diffuse large B-cell lymphoma.